Bio-Gene Technology (ASX:BGT)

Bio-Gene Technology Limited (ASX:BGT)

Bio-Gene Technology (ASX:BGT) is an Australian agtech development company enabling the next generation of safer insecticides. Its patent protected product platform is a new class of insecticides that seeks to address insecticide resistance.


Alphastation was engaged in Q3 2017 in preparation for its listing on the ASX in December 2017.


Alphastation created capital raising materials including:

  • Defined communication strategy and positioning aligned to the Bio-Gene corporate strategy
  • Completed the IPO prospectus for the company’s $8 million capital raising on the ASX including content drafting, refinement, design and layout
  • Liaison with company management, Board of Directors, legal advisor to the offers and broker to ensure project was delivered before deadline
  • Completed the IPO investor roadshow presentation
  • Conceived and executed diagrams and illustrations to convey the technology, product and market story

“We appointed Dom to assist with the drafting of the Prospectus and the supporting deck used in the IPO Roadshow. Dom did an excellent job making what otherwise would be an onerous task relatively painless.”

Roger McPherson, Bio-Gene Technology Limited (ASX:BGT)

Client since


IPO Prospectus, IPO Roadshow